The Duke Cancer Institute has launched the Thyroid Cancer Center, a multidisciplinary hub dedicated to delivering the highest level of care for patients with thyroid disease. The center is led by endocrine surgeon Randall Scheri, MD; endocrine oncologist Todd Frieze, MD; head and neck surgeon Russel Kahmke, MD; and head and neck oncologist Jameel Muzaffar, MD.
This center brings together a team of experts in endocrinology, surgery, oncology, and other specialties who will utilize the latest medical advances and minimally invasive procedures to ensure optimal outcomes.
“DCI’s Thyroid Cancer Center is built on a foundation of collaboration,” Scheri said. “Our subspecialized teams span across Durham and Raleigh, offering system-wide access to a full spectrum of thyroid care.”
Within the center, centralized pathways connect patients to specialists in endocrinology, endocrine surgery, head and neck surgery, medical oncology, pathology, nuclear medicine, radiation oncology, genetics, interventional radiology and orthopedic surgery. The center will also offer advanced care in pediatric endocrinology and endocrine surgery with high-volume expertise in pediatric thyroid cancer.
Patients will have access to state-of-the-art cancer genetics testing and specialized thyroid cytopathologists and surgical pathologists. Additionally, the center will offer a weekly Endocrine Tumor Conference, bringing together a multidisciplinary team to ensure patients receive a personalized, evidence-based treatment plan.
“The Thyroid Cancer Center will strive to provide compassionate, expert care for patients every step of the way,” Frieze said.
